Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

Details for Australian Patent Application No. 2004265547 (hide)

Owner Intrexon Corporation

Inventors Hormann, Robert Eugene; Le, Dat Phat; Chortyk, Orestes

Agent Davies Collison Cave

Pub. Number AU-B-2004265547

PCT Pub. Number WO2005/017126

Priority 10/783,810 19.02.04 US; 60/449,467 21.02.03 US

Filing date 20 February 2004

Wipo publication date 24 February 2005

Acceptance publication date 10 December 2009

International Classifications

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 498/10 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2005/017126 Priority application(s): WO2005/017126

14 June 2007 Assignment before Grant

  RheoGene Holdings, Inc. The application has been assigned to Intrexon Corporation

10 December 2009 Application Accepted

  Published as AU-B-2004265547

8 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004265550-RNA interference compositions and methods

2004265544-Systems and methods for controlling and forming polymer gels